5 Recruiting Myelodysplastic Syndromes Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for myelodysplastic syndromes enrolling across the USA. Verify eligibility and contact site coordinators.
All Myelodysplastic Syndromes studiesPhase 1 / Phase 2 Studies for Myelodysplastic Syndromes
🔵 Active, Not Recruiting Phase1 / Phase2
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
📍 West Virginia University Cancer Institute — Morgantown, West Virginia
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
📍 H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔